10 more Dengvaxia-related cases filed vs Garin, 37 others | Inquirer News

10 more Dengvaxia-related cases filed vs Garin, 37 others

By: - Reporter / @DYGalvezINQ
/ 03:42 PM October 30, 2018

A new batch of criminal complaints was filed on Tuesday before the Department of Justice against former Health Secretary Janette Garin and 37 others over deaths allegedly caused by the Dengvaxia vaccine.

Ten more families, assisted by the Public Attorneys’ Office (PAO), filed criminal cases against Garin, other health officials, and officials and personnel of vaccine manufacturer Sanofi Pasteur and its distributor, Zuellig Pharma.

Two of the criminal complaints have also named current Health Secretary Francisco Duque III as one of the respondents.

Article continues after this advertisement

Cases of reckless imprudence resulting in multiple homicide, torture, violations of the Consumer Protection Act (Republic Act 7394), particularly ‘defective product’ and ‘mislabeled product,’ were filed against the respondents.

FEATURED STORIES

Cases against the respondents also included obstruction of justice.

This is the third batch of criminal charges over Dengvaxia-related deaths that the PAO has filed at the DOJ. This brings to 27 the number of criminal cases filed against Garin and other respondents. /ee

Article continues after this advertisement

RELATED STORY: DepEd, DOH launch apps to monitor Dengvaxia cases

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Dengvaxia, News, Philippines

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.